Is Lead a Teratogen? How It Harms Fetal Development

Lead is a well-established teratogen, meaning it can cause structural and functional abnormalities in a developing fetus. The placenta offers essentially no barrier to it: maternal and fetal blood lead levels run nearly identical, so whatever is circulating in a pregnant person’s blood reaches the baby in roughly the same concentration. What makes lead especially insidious during pregnancy is that the body’s own hormonal changes can release decades-old lead stores from bone, raising blood levels even without any new environmental exposure.

How Lead Gets to the Fetus

The placenta is sometimes imagined as a filter that screens out harmful substances. For lead, that image is wrong. Research has shown there is no meaningful placental barrier to lead transport; the metal crosses freely from maternal to fetal circulation.¹ Lead is thought to cross via multiple routes: passive diffusion, piggybacking on calcium transport pathways, and hitching rides on metal-ion transporter proteins in the placental layers.²

The fact that lead follows calcium channels is central to understanding why pregnancy is a particularly dangerous time. During pregnancy and breastfeeding, the body ramps up bone resorption to supply calcium to the growing baby. Lead that has accumulated in bone over a lifetime gets swept into the bloodstream along with the calcium. One longitudinal study estimated that skeletal stores contributed roughly a third of the lead in pregnant women’s blood, with the range spanning from about 10% to nearly 90% depending on the individual. Even more striking, about 79% of the lead mobilized from the mother’s skeleton during pregnancy was transferred to the infant through cord blood.³ Low daily calcium intake made the problem worse, because the body had to pull more aggressively from bone reserves. Calcium supplementation during pregnancy has been associated with reduced bone resorption and lower blood lead levels, though it does not eliminate the mobilization entirely.⁴

Why Lead Is Biologically Damaging

Lead’s toxicity stems largely from its chemical similarity to calcium. Because lead ions mimic calcium, they slip into calcium-dependent processes throughout the body and disrupt them. In the developing brain, this means interference with neurotransmitter signaling, synaptic function, and the proteins involved in forming myelin, the insulation that wraps nerve fibers.⁵

Beyond calcium mimicry, lead triggers a cascade of oxidative stress. Animal studies have shown that prenatal and early-life lead exposure increases reactive oxygen species in the hippocampus (a brain region critical for learning and memory), depletes the body’s natural antioxidant defenses, and tips the balance toward cell death in developing neurons.⁶ Alongside this, lead exposure during development reduces levels of proteins essential for forming synapses, the junctions where neurons communicate, while ramping up inflammatory signaling.⁷ Lead also disrupts heme synthesis, the process the body uses to build the oxygen-carrying part of hemoglobin, in a dose-dependent fashion.⁸ For a fetus whose organs are forming and whose blood supply is expanding rapidly, all of these disruptions can converge at once.

Congenital Heart Defects

Among the structural birth defects linked to lead, congenital heart defects have received the most research attention. A meta-analysis pooling data across multiple studies found that maternal lead exposure was associated with roughly double the odds of having an infant with a congenital heart defect, with a pooled odds ratio of about 2.3.⁹ The association was not uniform across all heart defect subtypes. Lead showed the strongest links with conotruncal defects (problems with the major outflow tracts of the heart) and with left ventricular outflow tract obstruction.

A separate case-control study from China found that mothers with higher lead levels in their hair had roughly three times the odds of having a baby with a congenital heart defect compared to mothers with lower levels, and the researchers identified a dose-response pattern: the higher the lead, the greater the risk.¹⁰ While these studies cannot prove causation on their own, and other teratogenic exposures and genetic factors also play roles, the consistency of findings across different populations has strengthened the case for lead as a contributor to heart malformations.

Effects on Fetal Growth

Even at blood lead levels once considered low, lead exposure during pregnancy has been tied to reduced birth weight. A large study found that blood lead levels of 5 and 10 micrograms per deciliter were associated with average birth weight decreases of about 61 and 87 grams, respectively, compared to undetectable levels.¹¹ Those may sound like small numbers on a baby who weighs several pounds, but for infants who are already small, the reduction can matter clinically. A separate study found that the growth-restricting effect of lead was most pronounced among the smallest infants, suggesting that babies who are already vulnerable take a bigger hit.¹²

Beyond weight, cord blood lead levels have also been negatively associated with birth length. One study reported a significant drop in birth length for each increment of cord blood lead, and a parallel decrease in birth weight with rising maternal blood lead.¹³ The pattern across these studies is consistent: higher lead, smaller babies, even at exposure levels that many clinicians once dismissed as safe.

Effects on Brain Development

The developing brain is the organ most sensitive to lead. Lead damages the blood-brain barrier by injuring astrocytes, the support cells that help maintain it, which in turn damages the tiny blood vessels of the brain.¹⁴ With the barrier compromised, more lead and other harmful substances can enter brain tissue during the critical window when neurons are migrating, connecting, and pruning.

Animal research has shown that even low-level gestational lead exposure reduces the density of dendritic spines, the tiny protrusions on neurons where most synaptic connections form. In rats exposed to lead during development, spine density dropped in a dose-dependent manner in the hippocampus, and the animals subsequently performed worse on learning and memory tasks.¹⁵ In humans, prenatal lead exposure has been consistently associated with lower IQ scores and problems in several neurobehavioral domains, and researchers are now investigating whether even exposure below 5 micrograms per deciliter, the current CDC reference level, can affect executive function and social and emotional behavior in children.¹⁶

Pregnancy Complications

Lead exposure during pregnancy has been linked to complications that go beyond what happens to the fetus itself. Premature rupture of membranes, where the amniotic sac breaks before labor begins, occurs more frequently in women with higher lead levels. A large birth cohort study in China found that women in the highest third of urinary lead had about 50% greater odds of premature rupture of membranes compared to women in the lowest third, and the association was even stronger for preterm premature rupture.¹⁷ An earlier study had similarly observed that placentas from pregnancies complicated by premature rupture and preterm labor contained higher lead concentrations than those from term pregnancies, with about 41% of pregnancies showing abnormal outcomes when placental lead was above a threshold level versus roughly 9% below it.¹⁸

The evidence on miscarriage is more contested. A meta-analysis of eight studies found significantly higher lead concentrations in women who experienced spontaneous abortions compared to those who did not.¹⁹ An ecological study of the Washington, D.C. drinking water lead crisis found that fetal death rates tracked with water lead levels over roughly a decade, including spikes that followed the removal of public health protections for pregnant women.²⁰ However, a more recent systematic review cautioned that the overall certainty of evidence linking gestational lead exposure to miscarriage is low, largely because the human studies in this area face serious methodological challenges, including difficulty controlling for confounding factors.²¹ So while there is a plausible biological rationale and suggestive data, the link between low-level lead exposure and pregnancy loss is not as firmly established as the links to growth restriction or neurodevelopmental harm.

Epigenetic Changes That Can Span Generations

Some of the most unsettling research on prenatal lead exposure involves epigenetics, changes in how genes are read rather than changes to the DNA sequence itself. Lead exposure during pregnancy has been associated with altered DNA methylation patterns in cord blood. One study found that the more lead stored in a mother’s bones, the lower the methylation of certain repetitive DNA elements in the baby’s cord blood, in a clear dose-response pattern.²² Since methylation typically helps keep certain stretches of DNA quiet, reduced methylation could mean inappropriate gene activation during development.

Lead-related methylation changes have also been detected in the placenta itself. One study found hundreds of differentially methylated sites in placental tissue associated with prenatal lead levels, including changes in both methylation and hydroxymethylation that could affect how the placenta functions.²³ Perhaps most concerning is evidence suggesting these epigenetic marks can persist across generations. A study examining grandchildren of women who had elevated blood lead during pregnancy found hundreds of differentially methylated sites in the grandchildren’s cord blood, even after adjusting for the children’s own lead exposure, the mother’s age, and other potential confounders.²⁴ The practical health consequences of these multigenerational epigenetic changes are still being investigated, but the finding challenges the assumption that a toxicant’s effects end with the exposed generation.

No Known Safe Level

The CDC defines an elevated blood lead level as 5 micrograms per deciliter or greater, down from a previous threshold of 10. But the agency frames this as a reference value for triggering clinical follow-up, not as a safety threshold.²⁵ There is broad consensus that no level of lead exposure is safe, and several of the studies cited above found adverse effects in the range of 1 to 5 micrograms per deciliter. The dose-response curves for many outcomes, including birth weight and neurodevelopment, appear to be steepest at the lowest levels, which means the first increments of exposure may do proportionally more damage than later ones. This is an uncomfortable finding for public health because it means the most common, “low-level” exposures are not trivially low in their effects.

The Father’s Exposure Matters Too

Most discussions of lead and pregnancy focus on the mother, but paternal lead exposure is an emerging area of concern. Lead causes oxidative damage to sperm DNA and disrupts the epigenetic regulation of sperm by altering DNA methylation patterns. These changes can interfere with gene expression needed for proper embryonic development.²⁶

In a study of families with low-to-moderate environmental lead exposure, something unexpected emerged. Maternal and cord blood lead levels were not significantly associated with newborn measurements, but the father’s blood lead was. Higher paternal lead tracked with lower birth weight, shorter abdominal and head circumferences, and markers of DNA damage in the newborn. These associations were mainly confined to female babies.²⁷ This is a single study and the results need replication, but it raises the possibility that in populations where maternal exposure is relatively low, paternal exposure may be the bigger contributor to fetal harm, a dynamic that public health screening programs typically overlook.

Iron Deficiency Makes Everything Worse

Iron deficiency and lead exposure often cluster in the same populations, and the combination is more harmful than either alone. Women with anemia tend to have higher blood lead levels, likely because the body absorbs more lead from the gut when it is starved for iron, since lead and iron compete for the same absorption pathways.²⁸ The fetus then faces a double threat: impaired oxygen delivery from the anemia plus the direct toxic effects of elevated lead. This synergy is one reason why lead exposure is not just a toxicology problem but an equity problem. Communities with higher lead exposure from aging housing or contaminated water often have the same nutritional deficiencies that amplify lead’s effects.

What Can Be Done During Pregnancy

Treatment options for lead-exposed pregnant women are limited. Chelation therapy, which uses drugs to bind lead so it can be excreted, is not well studied in pregnancy, and its use is generally restricted to cases where the mother’s own health is at serious risk rather than used as a routine fetal-protective strategy.²⁹

Calcium supplementation is the most studied dietary intervention. Both animal and human research have shown that supplementing calcium during pregnancy and breastfeeding can reduce circulating blood lead levels, probably by slowing the rate at which the body pulls lead-laced calcium from bones.³⁰ A randomized trial found that the blood lead-lowering effect of calcium supplementation was greatest in women who had the highest bone lead stores, which makes biological sense: these are the women with the most stored lead to mobilize.³¹ Calcium supplementation is not a cure for lead exposure, but it represents one of the few practical strategies available to reduce fetal exposure in women who already carry lead in their bones. The primary prevention strategy remains the obvious one: reducing environmental lead contamination from paint, water pipes, soil, and industrial sources before anyone becomes pregnant.